# FDA Inspection 753392 - Raridon & Associates Inc - November 10, 2011

Source: https://www.keypedia.com/records/fda_inspections/raridon-associates-inc/8edc4daa-dbde-4ab3-94fa-1a0370c8b7ac
Source feed: FDA_Inspections

> FDA Inspection 753392 for Raridon & Associates Inc on November 10, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 753392
- Company Name: Raridon & Associates Inc
- Inspection Date: 2011-11-10
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 919721 - 2015-03-27](https://www.keypedia.com/records/fda_inspections/raridon-associates-inc/c11713f4-419c-4a41-be5d-ebe79f354744)
- [FDA Inspection 857751 - 2013-12-05](https://www.keypedia.com/records/fda_inspections/raridon-associates-inc/a4e71abd-775c-4c00-b412-1c85684f62fd)
- [FDA Inspection 656033 - 2010-03-24](https://www.keypedia.com/records/fda_inspections/raridon-associates-inc/af3b6b8c-352d-4a10-897f-7a6b96a870b1)

Company: https://www.keypedia.com/companies/raridon-associates-inc/0acb782a-4841-4194-bc85-5f4f120ff6ef

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d